Publicaciones en las que colabora con Miguel Ángel Piris Pinilla (56)

2023

  1. NanoString analysis of mycosis fungoides reveals individual molecular identity

    British Journal of Dermatology

2022

  1. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression

    Journal of Investigative Dermatology, Vol. 142, Núm. 5, pp. 1391-1400.e15

2018

  1. Mycosis fungoides progression could be regulated by microRNAs

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

    Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395

2015

  1. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma

    Haematologica

  2. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas

    Haematologica

2014

  1. Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: A clinicopathological study

    Modern Pathology, Vol. 27, Núm. 2, pp. 281-293

  2. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  3. PLCG1 mutations in cutaneous T-cell lymphomas

    Blood, Vol. 123, Núm. 13, pp. 2034-2043

  4. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

    Blood

  5. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. Erratum: MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma (Modern Pathology (2012) DOI; 10.1038/modpathol.2012.149)

    Modern Pathology

  2. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas

    Blood Cancer Journal, Vol. 3, Núm. 4

  3. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

  4. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

    Modern Pathology, Vol. 26, Núm. 2, pp. 171-181

  5. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

  6. TCR-γ expression in primary cutaneous T-cell lymphomas

    American Journal of Surgical Pathology, Vol. 37, Núm. 3, pp. 375-384

2012

  1. MicroRNA signatures in B-cell lymphomas

    Blood Cancer Journal, Vol. 2, Núm. 2

2011

  1. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

    Modern Pathology, Vol. 24, Núm. 5, pp. 698-707

2010

  1. Aggressive large B-cell lymphoma with plasma cell differentiation: Immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

    Haematologica, Vol. 95, Núm. 8, pp. 1342-1349